Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 3, 2026

Stock market today: Dow plunges over 1,000 points, S&P 500 and Nasdaq sink as oil surges amid war worries

View original at finance.yahoo.com
Stock market today: Dow plunges over 1,000 points, S&P 500 and Nasdaq sink as oil surges amid war worries US stocks sold off on Tuesday after Israel and US jets launched new strikes on Iran, as the widening conflict stoked worries about a drawn-out regional war…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Trump administration will roll out program to mitigate rising energy costs, hardest military hits on Iran yet to come

    80% confidence
  • Target should stay in penalty box and is a 'prove it' stock; investors should favor Walmart or Costco on pullbacks

    80% confidence
  • First quarter lift expected to banks' trading business from increased volatility across markets from Iran war

    80% confidence
  • US willing to deploy ground troops in Iran for whatever duration necessary

    80% confidence
  • Target market share was at least flat during holiday quarter, pointing to slightly softer customer demand for the industry

    80% confidence
  • Best Buy expects first quarter same-store sales to return to growth, rising 1%

    80% confidence
  • Markets will take initial cues from leaders running point on the war (Trump, Hegseth)

    80% confidence
  • Since 2009, S&P 500 has seen more than 30 pullbacks of greater than 5%, suggesting stocks can be resilient in face of bad news

    80% confidence
  • 10% increase in crude oil prices typically raises core inflation by 4 basis points and headline inflation by 20-30 basis points

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com
Stock market today: Dow plunges over 1,000 points, S&P 500 and Nasdaq sink as oil surges amid war worries — Source | Via News | ViaNews Market